Shantha Biologics to provide cartridge fill-finish services for Novo Nordisk
Shantha Biologics has entered a partnership with Novo Nordisk to provide cartridge fill-finish services for injectable medications at its Hyderabad facility. This agreement highlights India's growing role in advanced pharmaceutical manufacturing for global healthcare companies.
Why it matters
The deal underscores the shift of high-precision pharmaceutical manufacturing to India, supporting the production of high-demand drugs like insulin and obesity treatments.
Vaccine maker Shantha Biologics has signed an agreement with Novo Nordisk to manufacture cartridges for injectable medicines at its Hyderabad plant for the Danish pharmaceutical major.
The article is a straightforward business report detailing a corporate partnership without loaded language or political framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in